Cargando…
Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189478/ https://www.ncbi.nlm.nih.gov/pubmed/34106990 http://dx.doi.org/10.1371/journal.pone.0253252 |
| _version_ | 1783705504285982720 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8189478 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81894782021-06-16 Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial PLoS One Correction Public Library of Science 2021-06-09 /pmc/articles/PMC8189478/ /pubmed/34106990 http://dx.doi.org/10.1371/journal.pone.0253252 Text en © 2021 The PLOS ONE Staff https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title_full | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title_fullStr | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title_full_unstemmed | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title_short | Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial |
| title_sort | correction: 2-day versus c-reactive protein guided antibiotherapy with levofloxacin in acute copd exacerbation: a randomized controlled trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189478/ https://www.ncbi.nlm.nih.gov/pubmed/34106990 http://dx.doi.org/10.1371/journal.pone.0253252 |
| work_keys_str_mv | AT correction2dayversuscreactiveproteinguidedantibiotherapywithlevofloxacininacutecopdexacerbationarandomizedcontrolledtrial |